Merus NV【MRUS】株式ニュース

名称	銘柄コード	市場	種別
Merus NV	MRUS	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.32	-0.73%	43.40	06:52:14

始値	安値	高値	終値	前日終値
43.58	43.35	44.63	43.40	43.72

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/13	21:00	GLOBE	Petosemtamab granted Breakthrough Therapy Designation by the..
2024/5/11	05:33	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/5/10	05:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/09	05:15	GLOBE	Merus Announces Financial Results for the First Quarter 2024..
2024/5/08	21:01	EDGAR2	Form 8-K - Current report
2024/5/07	05:05	GLOBE	Merus Announces U.S. FDA Acceptance and Priority Review of..
2024/4/09	01:00	GLOBE	Merus Presents Preclinical Data Demonstrating Efficacy of..
2024/4/03	21:00	GLOBE	Merus to Participate in a Fireside Chat at the 23rd Annual..
2024/3/06	22:15	EDGAR2	Form 8-K - Current report
2024/3/06	22:00	BW	Gilead and Merus Announce Collaboration to Discover Novel..
2024/3/06	06:30	GLOBE	Merus Announces Publication of an Abstract for Presentation..
2024/3/04	22:00	GLOBE	Merus to Participate in a Fireside Chat at the Leerink..
2024/2/29	06:55	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2024/2/29	06:15	GLOBE	Merus Announces Financial Results for the Fourth Quarter and..
2024/2/15	06:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/31	22:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
2023/12/21	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/19	07:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/16	09:29	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/13	06:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/05	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/03	10:40	GLOBE	Merus Presents Interim Data on MCLA-129 at ESMO Asia..
2023/12/02	00:47	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/27	01:05	GLOBE	Merus Announces Publication of Abstracts on MCLA-129 for..
2023/11/03	05:12	GLOBE	Merus Announces Financial Results for the Third Quarter 2023..
2023/11/03	05:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01	21:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
2023/10/23	20:30	GLOBE	Merus’ Zeno Interim Data Continues to Demonstrate Robust and..
2023/10/16	08:58	GLOBE	Merus Announces Business Update Conference Call
2023/10/12	05:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/12	05:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/06	22:32	GLOBE	Merus Announces Abstracts Accepted for Presentation at the..
2023/8/31	21:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
2023/8/12	05:01	EDGAR2	Form 8-K - Current report
2023/8/11	22:00	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/10	10:53	GLOBE	Merus Announces Pricing of Public Offering of Common Shares
2023/8/10	05:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/10	05:01	GLOBE	Merus N.V. Announces Proposed Public Offering of Common..
2023/8/08	05:26	GLOBE	Merus Announces Financial Results for the Second Quarter..
2023/8/08	05:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/28	21:00	GLOBE	Merus Announces Two Clinical Abstracts on Zenocutuzumab..
2023/7/06	05:01	GLOBE	Zenocutuzumab (Zeno) granted second Breakthrough Therapy..
2023/6/30	05:30	GLOBE	Zenocutuzumab (Zeno) granted Breakthrough Therapy..
2023/6/15	20:47	GLOBE	Merus Appoints Life Sciences Strategic and Financial..